Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Neurocognitive × osimertinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 27 Lung Neoplasms 6 NSCLC 2 Meningeal Carcinomatosis 2 Bronchial Neoplasms 2 Brain Neoplasms 2 Non-Small Cell Lung Cancer With EGFR T790M Mutation 1 Neurocognitive 1 Advanced Non-small Cell Lung Cancer 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04829019 2021-04-02

Neurocognition in NSCLC Patients Treated With Osimertinib or Osimertinib + WBI

Sun Yat-sen University

Phase 2 Unknown

Neurocognitive

Data powered by HemOnc (CC BY 4.0) Colophon ⚡